GIORDANO, Giulia Maria
 Distribuzione geografica
Continente #
EU - Europa 5.743
NA - Nord America 3.578
AS - Asia 2.861
SA - Sud America 410
Continente sconosciuto - Info sul continente non disponibili 274
AF - Africa 32
OC - Oceania 2
Totale 12.900
Nazione #
RU - Federazione Russa 4.010
US - Stati Uniti d'America 3.470
SG - Singapore 990
IT - Italia 668
CN - Cina 539
IE - Irlanda 480
HK - Hong Kong 468
BR - Brasile 340
VN - Vietnam 294
KR - Corea 175
GB - Regno Unito 145
DE - Germania 120
JP - Giappone 115
IN - India 96
FR - Francia 66
TR - Turchia 64
CA - Canada 53
BD - Bangladesh 46
UA - Ucraina 44
GR - Grecia 41
FI - Finlandia 37
MX - Messico 24
SE - Svezia 24
AT - Austria 21
AR - Argentina 20
NL - Olanda 20
ES - Italia 16
ZA - Sudafrica 15
IQ - Iraq 13
EC - Ecuador 11
PL - Polonia 10
CL - Cile 9
CH - Svizzera 8
CO - Colombia 8
VE - Venezuela 8
PE - Perù 7
PK - Pakistan 7
JM - Giamaica 6
NO - Norvegia 6
SA - Arabia Saudita 6
BE - Belgio 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
MA - Marocco 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BO - Bolivia 4
EG - Egitto 4
IL - Israele 4
MY - Malesia 4
NI - Nicaragua 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
HN - Honduras 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
AM - Armenia 2
AU - Australia 2
CY - Cipro 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
KE - Kenya 2
LV - Lettonia 2
PH - Filippine 2
SV - El Salvador 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
DZ - Algeria 1
GE - Georgia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SN - Senegal 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 12.628
Città #
Moscow 1.445
San Jose 598
Dublin 472
Singapore 463
Hong Kong 457
Santa Clara 419
Ashburn 353
Council Bluffs 208
Seoul 172
Chandler 155
Ho Chi Minh City 114
Beijing 109
Naples 106
Hefei 99
Jacksonville 99
Milan 82
Aversa 81
Dallas 69
Los Angeles 69
New York 67
Princeton 67
Hanoi 66
Roxbury 58
Istanbul 57
Bengaluru 49
Cambridge 43
The Dalles 30
Caserta 29
São Paulo 28
Bremen 26
Orem 26
Rome 25
Memphis 24
Miano 24
Munich 24
Atlanta 22
Da Nang 21
San Francisco 19
Wilmington 19
Chicago 18
Des Moines 18
Afragola 17
Medford 17
Denver 16
Helsinki 14
Boardman 13
Frankfurt am Main 13
North Bergen 13
Toronto 13
Johannesburg 12
Montreal 12
Nuremberg 12
Brooklyn 11
Kochi 11
Falkenstein 10
Phoenix 10
Tokyo 10
Turku 10
Viterbo 10
Brasília 9
Lappeenranta 9
Manchester 9
Warsaw 9
Abbeville 8
Haiphong 8
London 8
Mexico City 8
Rio de Janeiro 8
Vienna 8
Woodbridge 8
Baghdad 7
Giugliano in Campania 7
Stockholm 7
Changsha 6
Chennai 6
Hải Dương 6
Madrid 6
Norwalk 6
Belo Horizonte 5
Boston 5
Hamburg 5
Houston 5
Kyiv 5
Manaus 5
Marzano di Nola 5
Philadelphia 5
Pune 5
Ribeirão Preto 5
Shanghai 5
Tulsa 5
Turin 5
Bergen 4
Birmingham 4
Brussels 4
Buffalo 4
Bến Tre 4
Canoas 4
Etobicoke 4
Guarulhos 4
Guayaquil 4
Totale 6.798
Nome #
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 298
EPA Guidance on treatment of cognitive impairment in schizophrenia 201
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 201
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 187
EPA guidance on assessment of negative symptoms in schizophrenia 182
Aetiopathological mechanisms of negative symptoms in schizophrenia 181
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 179
'Precision psychiatry' needs to become part of 'personalized psychiatry' 174
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 168
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study 166
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 161
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia 160
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 160
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 160
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 160
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 154
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 153
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 152
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity 152
Accuracy of self-assessment of real-life functioning in schizophrenia 150
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 148
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 147
EPA guidance on treatment of negative symptoms in schizophrenia 145
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 144
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 144
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 144
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 142
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 141
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 141
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping 139
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses 139
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 138
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 137
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 135
The relationship between the resting state functional connectivity and social cognition in schizophrenia: Results from the Italian Network for Research on Psychoses 133
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia 133
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning 132
Auditory P300 and cognition in schizophrenia: findings from a multicentre study 131
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review 130
Association of functional genetic variation in PP2A with prefrontal working memory processing 130
Disorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings 129
Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series 128
Sex and gender differences in clinical and functional indices in subjects with schizophrenia and healthy controls: Data from the baseline and 4-year follow-up studies of the Italian Network for Research on Psychoses 127
Functional connectivity of the ventral tegmental area and avolition in schizophrenia: A resting state functional MRI study 125
Neurobiology of Schizophrenia: Electrophysiological indices 125
Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review 125
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia 124
Illness-related variables and abnormalities of resting-state brain activity in schizophrenia 123
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study 123
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 123
Negative Symptom Domains in Children and Adolescents at Ultra-High Risk for Psychosis: Association with Real-Life Functioning 121
VTA-insula connectivity and avolition in subjects with schizophrenia 117
Depression and neurocognitive impairment: evaluation of their role as predictors of auditory N100 in schizophrenia 117
Investigating the relationships of p3b with negative symptoms and neurocognition in subjects with chronic schizophrenia 117
Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review 116
ELECTROPHYSIOLOGICAL CORRELATES OF AVOLITION-APATHY DOMAIN IN SCHIZOPHRENIA 116
Resting state functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia 114
DISORGANIZATION AND COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA: A STUDY OF RESTING STATE EEG 114
Neuroimaging: Diagnostic boundaries and biomarkers 114
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study 113
Factors Associated with Real-Life Functioning in Persons with Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 113
Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques (Front. Neurosci., (2020), 14, (632), 10.3389/fnins.2020.00632) 111
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning 110
Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: a resting state functional MRI study 110
Current goals of neuroimaging for mental disorders: a report by the WPA Section on Neuroimaging in Psychiatry 110
EPA guidance on assessment of cognitive impairment in schizophrenia 109
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 109
Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia 109
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia 108
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophrenia 108
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial 104
Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls 104
Prevalence of mental disorders and related risk factors in refugees and asylum seekers in Campania 102
Relationship between MMN and real-life functioning in subjects with schizophrenia 102
Effects of chronic antipsychotic treatment on neurophysiological correlates of the auditory oddball task in schizophrenia: A preliminary report from a multicentre study 101
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG 101
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 101
Inter-rater reliability and psychometric characteristics of the Italian version of the Cognitive Assessment Interview (CAI) 100
Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study 100
Laryngopharyngeal reflux and psychological distress: a vicious cycle worth investigating 100
Electrophysiological correlates of negative symptom domains in schizophrenia 99
MMN impairment in subjects with schizophrenia among different stages of disease 99
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophrenia 97
The efficacy, feasibility and acceptability of a remotely accessible use of circuits, a computerized cognitive remediation therapy program for schizophrenia: A pilot study 97
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 96
The dimensional structure of the Positive and Negative Syndrome Scale in first-episode schizophrenia spectrum disorders: an Exploratory Graph Analysis from the OPTiMiSE trial 94
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia 94
We are not ready to abandon the current schizophrenia construct, but should be prepared to do so 94
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 93
P3a and real-life functioning in a sample of chronic schizophrenia subjects 93
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 93
The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties 93
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 91
Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study 90
Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls 87
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study 87
Neglected Vulnerabilities in Mental Health: Where Do We Need to Do More? 86
Understanding the Pathophysiology of Mental Diseases and Early Diagnosis Thanks to Electrophysiological Tools: Some Insights and Empirical Facts 85
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study 85
Worldwide initiatives aimed to train professionals in the use of the ICD-11 84
Totale 12.632
Categoria #
all - tutte 43.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022405 0 0 0 12 106 16 14 8 17 71 38 123
2022/2023791 72 23 25 40 66 53 10 28 417 10 19 28
2023/2024468 25 24 37 39 134 46 9 10 7 9 32 96
2024/20251.899 7 19 11 142 263 265 260 147 256 263 136 130
2025/20267.393 343 485 331 302 609 3.749 446 304 241 297 201 85
2026/20271.410 63 380 466 501 0 0 0 0 0 0 0 0
Totale 12.900